Skip to main content
. 2023 Jul 4;28(12):4968–4976. doi: 10.1038/s41380-023-02161-5

Fig. 3. The gut–brain axis as a therapeutic target for long COVID.

Fig. 3

Patients with long COVID have persistent dysbiosis of the gut microbiome, resulting in a number of persistent GI symptoms, as well as neurological and psychiatric symptoms through the gut–brain axis. A plant-based diet, probiotics and prebiotics, and microbiome-derived metabolites [e.g., short-chain fatty acids (SCFAs: butyrate)] may have prophylactic or therapeutic potential for patients with long COVID. Given the role of the gut–microbiota–brain axis in neuroinflammation, fecal microbiota transplantation (FMT) from healthy controls may be a potential therapeutic tool for patients with long COVID. In addition, given the crucial role of the vagus nerve in the gut–brain axis, vagus nerve stimulation (VNS) could improve a number of neurological and psychiatric symptoms in patients with long COVID. This is a slight modification of a previously published figure [94]. Part of the figure was designed using resources from Biorender.com.